VIGABATRIN (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the VIGABATRIN drug offered from Par Pharmaceutical, Inc.. This Anti-epileptic Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: vigabatrin
SUBSTANCE NAME: VIGABATRIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-epileptic Agent [EPC]
ROUTE: ORAL
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-04-27
END MARKETING DATE: 0000-00-00


VIGABATRIN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVIGABATRIN from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 2017-04-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49884-358_4fa93c50-da5a-4aa7-aea2-01eab0d2f37f
PRODUCT NDC: 49884-358
APPLICATION NUMBER: ANDA208218

Other VIGABATRIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Lundbeck Pharmaceuticals LLCSABRIL
Par Pharmaceutical, Inc.VIGABATRIN